インスリンAPIのグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global Insulin API Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16439 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥487,200 (USD3,480)	▷ お問い合わせ
Multi User	￥730,800 (USD5,220)	▷ お問い合わせ
Corporate User	￥974,400 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

インスリンAPI市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のインスリンAPIの市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のインスリンAPIの市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 インスリンAPI市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・速効型インスリン、インスリンアナログ 用途別セグメントは次のように区分されます。 ・速効性、プレミックス、長時間作用型 世界のインスリンAPI市場の主要な市場プレーヤーは以下のとおりです。 ・Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetes、Torrent Pharma 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、インスリンAPI製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なインスリンAPIメーカーの企業概要、2019年～2021年までのインスリンAPIの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なインスリンAPIメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別インスリンAPIの販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのインスリンAPIの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのインスリンAPI市場予測を収録しています。 ・第12、13、14章では、インスリンAPIの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、Ganlee、United Laboratory、Biocon、Amphastar、Wockhardt、Julphar Diabetes、Torrent Pharma ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：速効型インスリン、インスリンアナログ ・用途別分析2016年-2026年：速効性、プレミックス、長時間作用型 ・インスリンAPIの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・インスリンAPIのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・インスリンAPIのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・インスリンAPIの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・インスリンAPIの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Insulin API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Insulin API size is estimated to be XX million in 2021 from USD 1741.5 million in 2020, with a change of XX% between 2020 and 2021. The global Insulin API market size is expected to grow at a CAGR of 2.8% for the next five years.

Market segmentation
Insulin API market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Regular Human Insulin
Insulin Analogue

Market segment by Application can be divided into
Fast-Acting
Premix
Long-Acting

The key market players for global Insulin API market are listed below:
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
Ganlee
United Laboratory
Biocon
Amphastar
Wockhardt
Julphar Diabetes
Torrent Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Insulin API product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Insulin API, with price, sales, revenue and global market share of Insulin API from 2019 to 2021.
Chapter 3, the Insulin API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Insulin API market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Insulin API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Insulin API Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Insulin API Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Regular Human Insulin
1.2.3 Insulin Analogue
1.3 Market Analysis by Application
1.3.1 Overview: Global Insulin API Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Fast-Acting
1.3.3 Premix
1.3.4 Long-Acting
1.4 Global Insulin API Market Size & Forecast
1.4.1 Global Insulin API Sales in Value (2016-2026))
1.4.2 Global Insulin API Sales in Volume (2016-2026)
1.4.3 Global Insulin API Price by Type (2016-2026) & (K US$/Kg)
1.5 Global Insulin API Production Capacity Analysis
1.5.1 Global Insulin API Total Production Capacity (2016-2026)
1.5.2 Global Insulin API Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Insulin API Market Drivers
1.6.2 Insulin API Market Restraints
1.6.3 Insulin API Trends Analysis
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Insulin API Product and Services
2.1.4 Novo Nordisk Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Sanofi-Aventis
2.2.1 Sanofi-Aventis Details
2.2.2 Sanofi-Aventis Major Business
2.2.3 Sanofi-Aventis Insulin API Product and Services
2.2.4 Sanofi-Aventis Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Eli Lilly
2.3.1 Eli Lilly Details
2.3.2 Eli Lilly Major Business
2.3.3 Eli Lilly Insulin API Product and Services
2.3.4 Eli Lilly Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Tonghua Dongbao
2.4.1 Tonghua Dongbao Details
2.4.2 Tonghua Dongbao Major Business
2.4.3 Tonghua Dongbao Insulin API Product and Services
2.4.4 Tonghua Dongbao Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Ganlee
2.5.1 Ganlee Details
2.5.2 Ganlee Major Business
2.5.3 Ganlee Insulin API Product and Services
2.5.4 Ganlee Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 United Laboratory
2.6.1 United Laboratory Details
2.6.2 United Laboratory Major Business
2.6.3 United Laboratory Insulin API Product and Services
2.6.4 United Laboratory Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Biocon
2.7.1 Biocon Details
2.7.2 Biocon Major Business
2.7.3 Biocon Insulin API Product and Services
2.7.4 Biocon Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Amphastar
2.8.1 Amphastar Details
2.8.2 Amphastar Major Business
2.8.3 Amphastar Insulin API Product and Services
2.8.4 Amphastar Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Wockhardt
2.9.1 Wockhardt Details
2.9.2 Wockhardt Major Business
2.9.3 Wockhardt Insulin API Product and Services
2.9.4 Wockhardt Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Julphar Diabetes
2.10.1 Julphar Diabetes Details
2.10.2 Julphar Diabetes Major Business
2.10.3 Julphar Diabetes Insulin API Product and Services
2.10.4 Julphar Diabetes Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Torrent Pharma
2.11.1 Torrent Pharma Details
2.11.2 Torrent Pharma Major Business
2.11.3 Torrent Pharma Insulin API Product and Services
2.11.4 Torrent Pharma Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Insulin API Sales by Manufacturer
3.1 Global Insulin API Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Insulin API Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Insulin API
3.4 Market Concentration Rate
3.4.1 Top 3 Insulin API Manufacturer Market Share
3.4.2 Top 6 Insulin API Manufacturer Market Share
3.5 Global Insulin API Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Insulin API Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Insulin API Market Size by Region
4.1.1 Global Insulin API Sales in Volume by Region (2016-2026)
4.1.2 Global Insulin API Revenue by Region (2016-2026)
4.2 North America Insulin API Revenue (2016-2026)
4.3 Europe Insulin API Revenue (2016-2026)
4.4 Asia-Pacific Insulin API Revenue (2016-2026)
4.5 South America Insulin API Revenue (2016-2026)
4.6 Middle East and Africa Insulin API Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Insulin API Sales in Volume by Type (2016-2026)
5.2 Global Insulin API Revenue by Type (2016-2026)
5.3 Global Insulin API Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Insulin API Sales in Volume by Application (2016-2026)
6.2 Global Insulin API Revenue by Application (2016-2026)
6.3 Global Insulin API Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Insulin API Sales by Type (2016-2026)
7.2 North America Insulin API Sales by Application (2016-2026)
7.3 North America Insulin API Market Size by Country
7.3.1 North America Insulin API Sales in Volume by Country (2016-2026)
7.3.2 North America Insulin API Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Insulin API Sales by Type (2016-2026)
8.2 Europe Insulin API Sales by Application (2016-2026)
8.3 Europe Insulin API Market Size by Country
8.3.1 Europe Insulin API Sales in Volume by Country (2016-2026)
8.3.2 Europe Insulin API Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Insulin API Sales by Type (2016-2026)
9.2 Asia-Pacific Insulin API Sales by Application (2016-2026)
9.3 Asia-Pacific Insulin API Market Size by Region
9.3.1 Asia-Pacific Insulin API Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Insulin API Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Insulin API Sales by Type (2016-2026)
10.2 South America Insulin API Sales by Application (2016-2026)
10.3 South America Insulin API Market Size by Country
10.3.1 South America Insulin API Sales in Volume by Country (2016-2026)
10.3.2 South America Insulin API Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Insulin API Sales by Type (2016-2026)
11.2 Middle East & Africa Insulin API Sales by Application (2016-2026)
11.3 Middle East & Africa Insulin API Market Size by Country
11.3.1 Middle East & Africa Insulin API Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Insulin API Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Insulin API Typical Distributors
12.3 Insulin API Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Insulin API Revenue by Type, (USD Million), 2021-2026
Table 2. Global Insulin API Revenue by Application, (USD Million), 2021-2026
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Insulin API Product and Services
Table 6. Novo Nordisk Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi-Aventis Major Business
Table 9. Sanofi-Aventis Insulin API Product and Services
Table 10. Sanofi-Aventis Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 12. Eli Lilly Major Business
Table 13. Eli Lilly Insulin API Product and Services
Table 14. Eli Lilly Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tonghua Dongbao Basic Information, Manufacturing Base and Competitors
Table 16. Tonghua Dongbao Major Business
Table 17. Tonghua Dongbao Insulin API Product and Services
Table 18. Tonghua Dongbao Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Ganlee Basic Information, Manufacturing Base and Competitors
Table 20. Ganlee Major Business
Table 21. Ganlee Insulin API Product and Services
Table 22. Ganlee Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. United Laboratory Basic Information, Manufacturing Base and Competitors
Table 24. United Laboratory Major Business
Table 25. United Laboratory Insulin API Product and Services
Table 26. United Laboratory Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Biocon Basic Information, Manufacturing Base and Competitors
Table 28. Biocon Major Business
Table 29. Biocon Insulin API Product and Services
Table 30. Biocon Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Amphastar Basic Information, Manufacturing Base and Competitors
Table 32. Amphastar Major Business
Table 33. Amphastar Insulin API Product and Services
Table 34. Amphastar Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 36. Wockhardt Major Business
Table 37. Wockhardt Insulin API Product and Services
Table 38. Wockhardt Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Julphar Diabetes Basic Information, Manufacturing Base and Competitors
Table 40. Julphar Diabetes Major Business
Table 41. Julphar Diabetes Insulin API Product and Services
Table 42. Julphar Diabetes Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Torrent Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Torrent Pharma Major Business
Table 45. Torrent Pharma Insulin API Product and Services
Table 46. Torrent Pharma Insulin API Sales (Kg), Price (K US$/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Insulin API Sales by Manufacturer (2019-2021e) & (Kg)
Table 48. Global Insulin API Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Insulin API, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Insulin API Production Capacity by Company, (Kg): 2020 VS 2021
Table 51. Head Office and Insulin API Production Site of Key Manufacturer
Table 52. Insulin API New Entrant and Capacity Expansion Plans
Table 53. Insulin API Mergers & Acquisitions in the Past Five Years
Table 54. Global Insulin API Sales by Region (2016-2021e) & (Kg)
Table 55. Global Insulin API Sales by Region (2021-2026) & (Kg)
Table 56. Global Insulin API Revenue by Region (2016-2021e) & (USD Million)
Table 57. Global Insulin API Revenue by Region (2021-2026) & (USD Million)
Table 58. Global Insulin API Sales by Type (2016-2021e) & (Kg)
Table 59. Global Insulin API Sales by Type (2021-2026) & (Kg)
Table 60. Global Insulin API Revenue by Type (2016-2021e) & (USD Million)
Table 61. Global Insulin API Revenue by Type (2021-2026) & (USD Million)
Table 62. Global Insulin API Price by Type (2016-2021e) & (K US$/Kg)
Table 63. Global Insulin API Price by Type (2021-2026) & (K US$/Kg)
Table 64. Global Insulin API Sales by Application (2016-2021e) & (Kg)
Table 65. Global Insulin API Sales by Application (2021-2026) & (Kg)
Table 66. Global Insulin API Revenue by Application (2016-2021e) & (USD Million)
Table 67. Global Insulin API Revenue by Application (2021-2026) & (USD Million)
Table 68. Global Insulin API Price by Application (2016-2021e) & (K US$/Kg)
Table 69. Global Insulin API Price by Application (2021-2026) & (K US$/Kg)
Table 70. North America Insulin API Sales by Country (2016-2021e) & (Kg)
Table 71. North America Insulin API Sales by Country (2021-2026) & (Kg)
Table 72. North America Insulin API Revenue by Country (2016-2021e) & (USD Million)
Table 73. North America Insulin API Revenue by Country (2021-2026) & (USD Million)
Table 74. North America Insulin API Sales by Type (2016-2021e) & (Kg)
Table 75. North America Insulin API Sales by Type (2021-2026) & (Kg)
Table 76. North America Insulin API Sales by Application (2016-2021e) & (Kg)
Table 77. North America Insulin API Sales by Application (2021-2026) & (Kg)
Table 78. Europe Insulin API Sales by Country (2016-2021e) & (Kg)
Table 79. Europe Insulin API Sales by Country (2021-2026) & (Kg)
Table 80. Europe Insulin API Revenue by Country (2016-2021e) & (USD Million)
Table 81. Europe Insulin API Revenue by Country (2021-2026) & (USD Million)
Table 82. Europe Insulin API Sales by Type (2016-2021e) & (Kg)
Table 83. Europe Insulin API Sales by Type (2021-2026) & (Kg)
Table 84. Europe Insulin API Sales by Application (2016-2021e) & (Kg)
Table 85. Europe Insulin API Sales by Application (2021-2026) & (Kg)
Table 86. Asia-Pacific Insulin API Sales by Region (2016-2021e) & (Kg)
Table 87. Asia-Pacific Insulin API Sales by Region (2021-2026) & (Kg)
Table 88. Asia-Pacific Insulin API Revenue by Region (2016-2021e) & (USD Million)
Table 89. Asia-Pacific Insulin API Revenue by Region (2021-2026) & (USD Million)
Table 90. Asia-Pacific Insulin API Sales by Type (2016-2021e) & (Kg)
Table 91. Asia-Pacific Insulin API Sales by Type (2021-2026) & (Kg)
Table 92. Asia-Pacific Insulin API Sales by Application (2016-2021e) & (Kg)
Table 93. Asia-Pacific Insulin API Sales by Application (2021-2026) & (Kg)
Table 94. South America Insulin API Sales by Country (2016-2021e) & (Kg)
Table 95. South America Insulin API Sales by Country (2021-2026) & (Kg)
Table 96. South America Insulin API Revenue by Country (2016-2021e) & (USD Million)
Table 97. South America Insulin API Revenue by Country (2021-2026) & (USD Million)
Table 98. South America Insulin API Sales by Type (2016-2021e) & (Kg)
Table 99. South America Insulin API Sales by Type (2021-2026) & (Kg)
Table 100. South America Insulin API Sales by Application (2016-2021e) & (Kg)
Table 101. South America Insulin API Sales by Application (2021-2026) & (Kg)
Table 102. Middle East & Africa Insulin API Sales by Country (2016-2021e) & (Kg)
Table 103. Middle East & Africa Insulin API Sales by Country (2021-2026) & (Kg)
Table 104. Middle East & Africa Insulin API Revenue by Country (2016-2021e) & (USD Million)
Table 105. Middle East & Africa Insulin API Revenue by Country (2021-2026) & (USD Million)
Table 106. Middle East & Africa Insulin API Sales by Type (2016-2021e) & (Kg)
Table 107. Middle East & Africa Insulin API Sales by Type (2021-2026) & (Kg)
Table 108. Middle East & Africa Insulin API Sales by Application (2016-2021e) & (Kg)
Table 109. Middle East & Africa Insulin API Sales by Application (2021-2026) & (Kg)
Table 110. Direct Channel Pros & Cons
Table 111. Indirect Channel Pros & Cons
Table 112. Insulin API Typical Distributors
Table 113. Insulin API Typical Customers
List of Figures
Figure 1. Insulin API Picture
Figure 2. Global Insulin API Sales Market Share by Type in 2020
Figure 3. Regular Human Insulin
Figure 4. Insulin Analogue
Figure 5. Global Insulin API Sales Market Share by Application in 2020
Figure 6. Fast-Acting
Figure 7. Premix
Figure 8. Long-Acting
Figure 9. Global Insulin API Market Size, (USD Million) & (Kg): 2020 VS 2021 VS 2026
Figure 10. Global Insulin API Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Insulin API Sales (2016-2026) & (Kg)
Figure 12. Global Insulin API Price by Type (2016-2026) & (K US$/Kg)
Figure 13. Global Insulin API Production Capacity (2016-2026) & (Kg)
Figure 14. Global Insulin API Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Insulin API Market Drivers
Figure 16. Insulin API Market Restraints
Figure 17. Insulin API Market Trends
Figure 18. Global Insulin API Sales Market Share by Manufacturer in 2020
Figure 19. Global Insulin API Revenue Market Share by Manufacturer in 2020
Figure 20. Insulin API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Insulin API Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Insulin API Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Insulin API Sales Market Share by Region (2016-2026)
Figure 24. Global Insulin API Revenue Market Share by Region (2016-2026)
Figure 25. North America Insulin API Revenue (2016-2026) & (USD Million)
Figure 26. Europe Insulin API Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Insulin API Revenue (2016-2026) & (USD Million)
Figure 28. South America Insulin API Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Insulin API Revenue (2016-2026) & (USD Million)
Figure 30. Global Insulin API Sales Market Share by Type (2016-2026)
Figure 31. Global Insulin API Revenue Market Share by Type (2016-2026)
Figure 32. Global Insulin API Price by Type (2016-2026) & (K US$/Kg)
Figure 33. Global Insulin API Sales Market Share by Application (2016-2026)
Figure 34. Global Insulin API Revenue Market Share by Application (2016-2026)
Figure 35. Global Insulin API Price by Application (2016-2026) & (K US$/Kg)
Figure 36. North America Insulin API Sales Market Share by Type (2016-2026)
Figure 37. North America Insulin API Sales Market Share by Application (2016-2026)
Figure 38. North America Insulin API Sales Market Share by Country (2016-2026)
Figure 39. North America Insulin API Revenue Market Share by Country (2016-2026)
Figure 40. United States Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Insulin API Sales Market Share by Type (2016-2026)
Figure 44. Europe Insulin API Sales Market Share by Application (2016-2026)
Figure 45. Europe Insulin API Sales Market Share by Country (2016-2026)
Figure 46. Europe Insulin API Revenue Market Share by Country (2016-2026)
Figure 47. Germany Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Insulin API Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Insulin API Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Insulin API Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Insulin API Revenue Market Share by Region (2016-2026)
Figure 56. China Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Insulin API Sales Market Share by Type (2016-2026)
Figure 63. South America Insulin API Sales Market Share by Application (2016-2026)
Figure 64. South America Insulin API Sales Market Share by Country (2016-2026)
Figure 65. South America Insulin API Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Insulin API Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Insulin API Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Insulin API Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Insulin API Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Insulin API Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

---